8451 - 8500 of 9030 Results
Title
Year
-
OPENTitle: A high-resolution map of the human small non-coding transcriptomeJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 10Start Page: 1621End Page: 1628Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/34/10/1621/25118245/btx814.pdfCitation Count: 28
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 15
- Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait?2020RESTRICTEDTitle: Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait?Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 2Start Page: 658End Page: 668Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-10089-xCitation Count: 32
-
OPENTitle: α-synuclein seed amplification in Parkinson‘s diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 984End Page: 985Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00374-5Best OA location URL: http://www.thelancet.com/article/S1474442223003745/pdfCitation Count: 3
-
OPENTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 25
-
OPENTitle: BAG5 Inhibits Parkin and Enhances Dopaminergic Neuron DegenerationJournal Name: NeuronPublisher: Elsevier BVVol: 44Issue #: 6Start Page: 931End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2004.11.026Best OA location URL: http://www.cell.com/article/S0896627304007627/pdfCitation Count: 200
-
OPENTitle: Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control StudyJournal Name: Basic & Clinical Pharmacology & ToxicologyPublisher: WileyVol: 138Issue #: 6Start Page: e70249End Page: e70249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcpt.70249Best OA location URL: https://doi.org/10.1111/bcpt.70249Citation Count: 0
- Cortical structural involvement and cognitive dysfunction in early Parkinson's disease2018RESTRICTEDTitle: Cortical structural involvement and cognitive dysfunction in early Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 31Issue #: 4Start Page: e3900End Page: e3900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/nbm.3900Citation Count: 8
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 677
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001Citation Count: 0
-
OPENTitle: Lack of association between G6PD variants and Parkinson diseaseJournal Name: Human Genetics and Genomics AdvancesPublisher: Elsevier BVVol: 7Issue #: 1Start Page: 100555End Page: 100555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.xhgg.2025.100555Best OA location URL: https://doi.org/10.1016/j.xhgg.2025.100555Citation Count: 0
-
RESTRICTEDTitle: Establishing the relationship between brain cellular senescence and brain structureJournal Name: CellPublisher: Elsevier BVVol: 189Issue #: 2Start Page: 511End Page: 527.e17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2025.10.014Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13202612/Citation Count: 1
- Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease2021RESTRICTEDTitle: Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 111End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.005Citation Count: 15
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 66
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice2015OPENTitle: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 172End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031Best OA location URL: http://doi.org/10.1016/j.nbd.2015.02.031Citation Count: 276
- Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease2018RESTRICTEDTitle: Tissue engineered nigrostriatal pathway for treatment of Parkinson's diseaseJournal Name: Journal of Tissue Engineering and Regenerative MedicinePublisher: WileyVol: 12Issue #: 7Start Page: 1702End Page: 1716Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/term.2698Citation Count: 63
-
OPENTitle: Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 162End Page: 162Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00423-7Best OA location URL: https://www.nature.com/articles/s41531-022-00423-7.pdfCitation Count: 62
-
OPENTitle: Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synucleinJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261431108End Page: 1877718X261431108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/1877718x261431108Best OA location URL: https://doi.org/10.1177/1877718x261431108Citation Count: 0
-
OPENTitle: New insights from a Malaysian real-world deep brain stimulation cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 1Start Page: 189End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241297715Best OA location URL: https://doi.org/10.1177/1877718x241297715Citation Count: 4
- The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease2015RESTRICTEDTitle: The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 262Issue #: 11Start Page: 2443End Page: 2447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-015-7868-3Citation Count: 27
-
OPENTitle: Advances in the genetics and pathology of Lewy body dementiaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 24Issue #: 12Start Page: 1026End Page: 1037Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(25)00363-1Best OA location URL: https://hdl.handle.net/2123/34700Citation Count: 4
- Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease2018RESTRICTEDTitle: Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative diseaseJournal Name: Current Opinion in ToxicologyPublisher: Elsevier BVVol: 7Issue #:Start Page: 127End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cotox.2018.02.003Citation Count: 21
-
OPENTitle: Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis GenesJournal Name: Human MutationPublisher: WileyVol: 2023Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/8620557Best OA location URL: https://downloads.hindawi.com/journals/humu/2023/8620557.pdfCitation Count: 2
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 36
-
OPENTitle: An Experimental Approach for Investigating Freezing of Gait in Parkinson’s Disease Using Virtual Reality and Neural Sensing: A Pilot StudyJournal Name: SensorsPublisher: MDPI AGVol: 25Issue #: 13Start Page: 4036End Page: 4036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s25134036Best OA location URL: https://www.mdpi.com/1424-8220/25/13/4036/pdf?version=1751100345Citation Count: 1
-
OPENTitle: Splicing accuracy varies across human introns, tissues, age and diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 1068End Page: 1068Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-55607-xBest OA location URL: https://www.nature.com/articles/s41467-024-55607-x.pdfCitation Count: 19
-
OPENTitle: Fox Insight: Most Bothersome Symptoms in Early‐Stage Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 4Start Page: 510End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14321Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14321Citation Count: 7
-
OPENTitle: Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegenerationJournal Name: Fluids and Barriers of the CNSPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 38End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12987-025-00646-9Best OA location URL: https://fluidsbarrierscns.biomedcentral.com/counter/pdf/10.1186/s12987-025-00646-9Citation Count: 8
-
OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page: 11158End Page: 11176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Best OA location URL: https://doi.org/10.1093/nar/gkae776Citation Count: 4
-
OPENTitle: Serotonergic and dopaminergic control of impulsivity in gambling disorderJournal Name: Addiction BiologyPublisher: WileyVol: 28Issue #: 2Start Page: e13264End Page: e13264Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/adb.13264Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/adb.13264Citation Count: 17
-
OPENTitle: Structural basis for the pathogenicity of parkin catalytic domain mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 301Issue #: 1Start Page: 108051End Page: 108051Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2024.108051Best OA location URL: https://www.jbc.org/article/S0021-9258(24)02553-5/pdfCitation Count: 7
-
OPENTitle: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**Journal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page: e202212063End Page: e202212063Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.202212063Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202212063Citation Count: 24
-
OPENTitle: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein SpreadingJournal Name: Advanced SciencePublisher: WileyVol: 12Issue #: 25Start Page: e2413052End Page: e2413052Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202413052Best OA location URL: https://doi.org/10.1002/advs.202413052Citation Count: 5
-
OPENTitle: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasetsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 38Issue #:Start Page: 103405End Page: 103405Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103405Citation Count: 70
-
OPENTitle: echolocatoR : an automated end-to-end statistical and functional genomic fine-mapping pipelineJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 2Start Page: 536End Page: 539Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10060715/pdf/btab658.pdfCitation Count: 36
- Alterations in sleep-activity cycles and clock gene expression across the synucleinopathy spectrum2025OPENTitle: Alterations in sleep-activity cycles and clock gene expression across the synucleinopathy spectrumJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-025-00492-7Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-025-00492-7Citation Count: 3
-
OPENTitle: Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazoneJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 20Issue #: 5Start Page: e0309489End Page: e0309489Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0309489Best OA location URL: https://doi.org/10.1371/journal.pone.0309489Citation Count: 0
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease2022OPENTitle: Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 39End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00300-3Best OA location URL: https://www.nature.com/articles/s41531-022-00300-3.pdfCitation Count: 37
-
OPENTitle: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 65End Page: 65Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00907-2Best OA location URL: https://www.nature.com/articles/s41531-025-00907-2.pdfCitation Count: 10
-
OPENTitle: FLIMPA: A Versatile Software for Fluorescence Lifetime Imaging Microscopy Phasor AnalysisJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 97Issue #: 22Start Page: 11382End Page: 11387Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.5c00495Best OA location URL: https://doi.org/10.1021/acs.analchem.5c00495Citation Count: 6
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 5907End Page: 5907Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 220
-
OPENTitle: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental ApproachJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 1Start Page: 9End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms26010009Best OA location URL: https://www.mdpi.com/1422-0067/26/1/9/pdf?version=1735026493Citation Count: 6
- A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)2024RESTRICTEDTitle: A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)Journal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 91Issue #:Start Page: 106008End Page: 106008Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2024.106008Citation Count: 13
-
OPENTitle: Plasma-borne indicators of inflammasome activity in Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00147-6Best OA location URL: https://www.nature.com/articles/s41531-020-00147-6.pdfCitation Count: 82
-
OPENTitle: Non-Motor Symptoms as Markers of Disease Severity in Parkinson’s Disease: Associations Between Constipation, Depression, REM Sleep Behavior Disorder, and Motor ImpairmentJournal Name: BiomedicinesPublisher: MDPI AGVol: 13Issue #: 11Start Page: 2704End Page: 2704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3390/biomedicines13112704Best OA location URL: https://www.mdpi.com/2227-9059/13/11/2704/pdf?version=1762184201Citation Count: 0
-
OPENTitle: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body DementiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 14Start Page: 3011End Page: 3024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/14/3011.full.pdfCitation Count: 51
-
OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 147
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26923Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26923Citation Count: 21
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 19
- multiplierz v2.0: A Python‐based ecosystem for shared access and analysis of native mass spectrometry data2017RESTRICTEDTitle: multiplierz v2.0: A Python‐based ecosystem for shared access and analysis of native mass spectrometry dataJournal Name: PROTEOMICSPublisher: WileyVol: 17Issue #: 15-16Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmic.201700091Citation Count: 50